Cite Filings / DFTX / 0000950170-23-028954

Feed Companies Filings Check

Sign in

8-K

Current Report

Definium Therapeutics, Inc. Filed 2023-06-20 Acc 0000950170-23-028954

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , mnmd-20230620.htm

Around this filing

2023-06-27 8-K Shareholder vote results
2023-06-23 4 Director acquired 13,671 shares (grant or award)
2023-06-23 4 Director acquired 13,671 shares (grant or award)
2023-06-23 4 Director acquired 13,671 shares (grant or award)
2023-06-23 3 Initial Statement of Ownership
2023-06-20 8-K Regulation FD disclosure
2023-06-16 8-K Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading mnmd-20230620.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…